Ling Guanghui

[Expert Profile] Ling Guanghui, Chief Physician, Professor, Doctoral Supervisor, is a renowned expert in rare immunological diseases in China, working in the Department of Rheumatology, The Second Xiangya Hospital, Central South University. He has long been dedicated to the clinical diagnosis, treatment, and scientific research of hereditary angioedema and rare immunological diseases, and is an important scholar in the field of rare rheumatic diseases in China.

[Education & Career] Professor Ling Guanghui graduated from Xiangya Medical College, completed systematic clinical training at the Second Xiangya Hospital, and has long been engaged in clinical, teaching, and research work in rheumatology. He has held academic positions in organizations such as the Rheumatology Branch of the Hunan Medical Association, and has presided over grants from the National Natural Science Foundation of China and provincial and ministerial research programs, accumulating extensive diagnosis and treatment experience in rare immunological diseases such as hereditary angioedema.

[Areas of Expertise] Professor Ling specializes in precise diagnosis and long-term management of hereditary angioedema (HAE), the diagnosis and treatment of various rare immunological diseases, as well as standardized management of common rheumatic diseases such as systemic lupus erythematosus and rheumatoid arthritis. He has extensive experience in C1 inhibitor deficiency assessment, acute attack treatment, and long-term prophylactic therapy for hereditary angioedema. He excels at identifying rare cases of "recurrent limb, facial, and laryngeal edema" that are easily misdiagnosed as allergies, helping patients avoid life-threatening complications such as fatal laryngeal edema.

[Academic Achievements & Industry Contributions] Professor Ling has conducted a series of clinical studies in the fields of hereditary angioedema and rare immunological diseases, systematically summarizing clinical features and diagnosis/treatment experiences of Chinese patients, with findings published in authoritative domestic and international journals. He has actively participated in the development of China's rare disease catalog and diagnostic standards, promoted the popularization of early identification, early diagnosis, and standardized treatment concepts for hereditary angioedema, and organized rare disease multidisciplinary consultations and patient education, making important contributions to improving the care level of rare immunological diseases and enhancing patient quality of life in China.

[Clinical Practice & Outstanding Contributions] Professor Ling has long held expert rheumatology clinics, cumulatively treating tens of thousands of patients with hereditary angioedema and various immunological conditions, providing clear diagnoses and protection from fatal risks for numerous patients with "recurrent edema of unknown origin." He is patient and responsible with patients, insisting on long-term follow-up and whole-course management, and is deeply trusted by patients. He has repeatedly organized rare disease science popularization and free clinics, actively promoting social awareness and care for rare immunological diseases, and is a warm physician in the hearts of patients.

[Honors & Reputation] Professor Ling Guanghui serves as Director of the Rheumatology Department at the Second Xiangya Hospital, among other academic positions. He has presided over grants from the National Natural Science Foundation of China and provincial and ministerial research programs, and is an important expert in rheumatology in central-south China. He has profound expertise in the diagnosis and treatment of difficult conditions such as hereditary angioedema and rare immunological diseases. He has led the establishment of a multidisciplinary diagnosis, treatment, and follow-up system for rare immunological diseases, promoted the implementation of genetic diagnosis and standardized treatment, and participated in the development of multiple rheumatology diagnosis and treatment guidelines. For decades on the clinical front lines, he has helped numerous rare immunological patients receive clear diagnoses, standardized management, and reduced attack frequency, and is deeply trusted by patients and respected by peers alike.